J Drbal
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
- Genetics 4
- Chronic Lymphocytic Leukemia Research 4
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- L Deschênes (1 shared paper)Bernardo L. Rapoport (1 shared paper)V. Trillet-Lenoir (1 shared paper)Matti Aapro (1 shared paper)W.R. Bezwoda (1 shared paper)M Murawsky (1 shared paper)R. Rosso (1 shared paper)David Melnychuk (1 shared paper)
- Journals
- PubMed (4 papers)European Journal of Cancer and Clinical Oncology (1 paper)
In The Last Decade
J Drbal
5 papers receiving 38 citations
Peers
Comparison fields: 5 of 22
- Cancer Research 20
- Oncology 32
- Dermatology 7
- Biological Psychiatry 1
- Toxicology 1
Countries citing papers authored by J Drbal
This map shows the geographic impact of J Drbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Drbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Drbal more than expected).
Fields of papers citing papers by J Drbal
This network shows the impact of papers produced by J Drbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Drbal. The network helps show where J Drbal may publish in the future.
Co-authors
The 17 scholars most cited alongside J Drbal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer. | 1997 | 31 |
| 2 | High dose alpha-2-recombinant interferon in the treatment of malignant lymphoproliferative diseases. A pilot study. | 1989 | 3 |
| 3 | 1988 | 2 | |
| 4 | Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapy. | 2004 | 2 |
| 5 | Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute. | 2000 | 1 |
About J Drbal
J Drbal is a scholar working on Genetics, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology and Clinical Biochemistry, having authored 5 papers that have together received 39 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Metabolism and Genetic Disorders (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Cancer Treatment and Pharmacology (1 paper), Breast Cancer Treatment Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Polyomavirus and related diseases (1 paper). The work is most often cited by research in Cancer Research (20 citations), Oncology (32 citations), Dermatology (7 citations), Biological Psychiatry (1 citation) and Toxicology (1 citation). J Drbal has collaborated with scholars based in Czechia, Russia and Canada. Frequent co-authors include L Deschênes, Bernardo L. Rapoport, V. Trillet-Lenoir, Matti Aapro, W.R. Bezwoda, M Murawsky, R. Rosso, David Melnychuk, Ted Vandenberg and A. Riva. Their work appears in journals such as PubMed and European Journal of Cancer and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.